---
title: Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction
  of Outcome in <em>KIT</em> D816V-Negative Advanced Systemic Mastocytosis
date: '2024-02-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38339343/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240210170637&v=2.18.0
source: heidelberg[Affiliation]
description: 'Within our nationwide registry, we identified a KIT D816V mutation (KIT
  D816V^(pos.)) in 280/299 (94%) patients with advanced systemic mastocytosis (AdvSM).
  Age, cytopenias and the presence of additional somatic mutations confer inferior
  overall survival (OS). However, little is known about the characteristics of KIT
  D816V-negative (D816V^(neg.)) AdvSM. In 19 D816V^(neg.) patients, a combination
  of clinical, morphological and genetic features revealed three subgroups: (a) KIT
  D816H- ...'
disable_comments: true
---
Within our nationwide registry, we identified a KIT D816V mutation (KIT D816V^(pos.)) in 280/299 (94%) patients with advanced systemic mastocytosis (AdvSM). Age, cytopenias and the presence of additional somatic mutations confer inferior overall survival (OS). However, little is known about the characteristics of KIT D816V-negative (D816V^(neg.)) AdvSM. In 19 D816V^(neg.) patients, a combination of clinical, morphological and genetic features revealed three subgroups: (a) KIT D816H- ...